Why the study?
Does dyslipidemia predict reduced survival in patients with pulmonary embolism?
Does dyslipidemia predict reduced survival in patients with pulmonary embolism?
Dyslipidemia serves as a long-term negative prognostic marker for survival in patients with pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Dyslipidemia may mark higher mortality risk in pulmonary embolism; leaves open need for trials on lipid intervention.
To analyse survival rate after 24 months in consecutive patients with a diagnosis of PE as well as associated factors. Prospective cohort study during a follow-up period of two years in a series of consecutive patients with PE. During the follow-up period, 34 out of 148 patients died (23%). Factors independently associated with reduced survival rate were: creatinine levels > 2 (OR, 8.8; 95% CI, 1.1 - 70.87), previous neoplasm (OR, 8.8; 95% CI, 3.69 - 20.98), dementia (OR, 6.85; 95% CI, 2.1 - 22.33) and dyslipidemia (OR, 5.07; 95% CI, 1.92 - 13.44). Forty four percent of the patients with dyslipidemia died vs. 20.8% of patients without this condition. In our study dyslipidemia shows as a long-term negative prognostic marker for survival in patients with EP. Analisar a taxa de sobrevivência após 24 meses, em pacientes consecutivos com diagnóstico de PE, bem como fatores associados. Estudo prospectivo durante um período de seguimento de dois anos em uma série consecutiva de pacientes com PE. Durante o período de acompanhamento, 34 dos 148 pacientes morreram (23%). Fatores independentemente associados à reduzida taxa de sobrevivência foram: os níveis de creatinina> 2 (OR, 8,8; 95% CI, 1,1-70,87), neoplasia anterior (OR, 8,8; IC 95%, 3,69-20,98), demência (OR, 6,85; 95% CI, 2,1-22,33) e dislipidemia (OR, 5,07; IC 95%, 1,92-13,44). Quarenta e quatro por cento dos pacientes com dislipidemia morreram contra 20,8% dos pacientes sem essa condição. No nosso estudo, a dislipidemia mostra-se um marcador prognóstico negativo de longo prazo na sobrevida de pacientes com EP.
No takes yet. Share an insight, caveat, or question.
Jara‐Palomares et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: